FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Clears Neocis Dental Implant Robot Guidance

FDA clears a Neocis Inc. 510(k) for Yomi, a robotic guidance system for dental implant procedures.

Human Drugs

Juno Scraps CAR-T Cell Product Development

Juno Therapeutics halts development of its CAR-T cell product candidate JCAR015, indicated for relapsed or refractory B cell acute lymphoblastic leuke...

Human Drugs

FDA Should Clarify Antibiotic Guidances: GAO

GAO says FDA should develop a guidance to help antibiotic drug sponsors under the qualified infectious disease product designation and its incentives.

Biologics

Dynavax Responds to Heplisav-B BLA Complete Response

FDA accepts a Dynavax Technologies submission that addresses an 11/2016 Complete Response Letter for its BLA for Heplisav-B [hepatitis Bb vaccine, rec...

Medical Devices

PA Court Allows Medical Device Strict Liability Claim

Attorney Michelle Yeary says that a Pennsylvania court erred in ruling that a medical device strict liability case could proceed.

Human Drugs

U.S., EU Drug Inspection Agreement

FDA and the EU finalize a mutual recognition agreement to allow drug inspectors to rely on information from inspections each party conducts.

Human Drugs

FDA Warns Wockhardts Morton Grove Unit

Indias Money Control Web site reports that Morton Grove Pharmaceuticals, a Wockhardt subsidiary, has received an FDA Warning Letter.

Human Drugs

Gilead Wants NCE Exclusivity for Stribild, 2 Others

Gilead asks FDA for five-year NCE exclusivity for its Stribild and two other products under a court ruling rejecting the agencys NCE exclusivity polic...

Human Drugs

GDUFA 2 Aims to Improve First-cycle ANDA Reviews: Woodcock

CDER director Janet Woodcock tells a House hearing that the second iteration of the Generic Drug User Fee Act will aim to improve first-cycle review a...

FDA General

Keep Venture Capitalists Away from FDA: Whistleblower

Acclarent whistleblower Melayna Lokosky says venture capitalists including Scott Gottlieb should not be given any role in running FDA.